Nuzenio

Mironid Secures

Mironid Secures news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Biotech Firm Secures 39.9 Million Euro for Kidney Research - N24 HaberN24 Haber · Sat, 08 Aug 2026 23:16:26 GMT Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMT Mironid raises USD 46m to advance first-in-class ADPKD therapy - AllSciAllSci · Wed, 05 Aug 2026 15:58:20 GMT Glasgow Biotech Mironid Secures £34m Series B Funding - digit.fyidigit.fyi · Wed, 05 Aug 2026 15:34:16 GMT Mironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.ukeurekamagazine.co.uk · Wed, 05 Aug 2026 13:37:33 GMT Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 05 Aug 2026 11:02:58 GMT Roche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 08:06:57 GMT Mironid - Via RitzauVia Ritzau · Wed, 05 Aug 2026 06:00:00 GMT

Timeline

Sat, 08 Aug 2026 23:16:26 GMTBiotech Firm Secures 39.9 Million Euro for Kidney Research - N24 Haber

Fri, 07 Aug 2026 12:14:34 GMTGlasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-Startups

Wed, 05 Aug 2026 15:58:20 GMTMironid raises USD 46m to advance first-in-class ADPKD therapy - AllSci

Wed, 05 Aug 2026 15:34:16 GMTGlasgow Biotech Mironid Secures £34m Series B Funding - digit.fyi

Wed, 05 Aug 2026 13:37:33 GMTMironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.uk

Wed, 05 Aug 2026 11:02:58 GMTMironid banks $46m in Series B to take rare kidney disease drug closer to clinic - Pharmaceutical Technology

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Mironid7 live mentions Series B4 live mentions Secures3 live mentions Million Euro2 live mentions Kidney Research2 live mentions Haber2 live mentions USD2 live mentions ADPKD2 live mentions Glasgow Biotech Mironid2 live mentions Series B Funding2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mironid Secures.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.